December 2025

Endovascular grafts recalled due to risk of coating breaking off, entering bloodstream ()
Healthcare advocacy in 2025: American Society of Echocardiography reviews a busy year ()
FDA finalizes Class I recall for Medtronic catheters ()
FDA confirms new recall for Johnson & Johnson heart device over safety concerns ()
Medtronic’s diabetes spin-off files for IPO ()
New strategies for intravascular imaging and physiological assessments in the cath lab ()
Bleeding reversal agent pulled from market over FDA’s safety concerns ()
Abbott PFA system gains FDA approval ()
FDA approves new drug for genetic heart disease ()
ACC calls for better management of peripheral artery disease in diabetic patients ()
SCAI town hall addresses workforce concerns in interventional cardiology ()
New PFA registry will use AI, EHR integration to gather real-world data ()
Cardiology’s biggest trend: New scientific statements take on AI-powered coronary plaque evaluations ()
Success in treating congenital heart disease prompted need for new adult guidelines ()
AI flags hard-to-detect heart disease in seconds ()
Cardiology needs to evolve in the face of employment trends ()
FDA clears Abbott delivery device for closing holes in the hearts of premature infants ()
TAVR or SAVR? Market competition may be influencing these decisions ()
Societies must adapt to the rise of multimodality cardiac imaging ()
Surgeons use modified ‘frozen elephant trunk’ technique for first heart surgery of its kind ()
Women drugged, raped by cardiologist file lawsuit against online dating apps ()
How to get reimbursed for renal denervation ()
American College of Cardiology highlights the cardiovascular risks of various cancer treatments ()
CMS considers Medicare coverage for TAVR in asymptomatic patients ()
Newest TAVR valve from Edwards Lifesciences improves survival, real-world data confirm ()
Cardiologist dies in fire after arrest for child sex abuse materials ()
Women are more likely to have severe aortic stenosis missed on echocardiography results ()
New Medtronic thrombectomy system used commercially for first time ()
FDA approves new nasal spray for patients with abnormal heart rhythms ()
Philips to acquire AI-enabled intravascular imaging specialists SpectraWAVE ()
FDA clears next-generation cardiac mapping software ()
More interventional procedures may be coming to an ambulatory surgical center near you ()
New recalls announced for troubled heart devices—FDA previously urged customers to seek alternatives ()
AI-powered FFR-CT software linked to considerable cost savings, accurate predictions ()
Cardiologist reportedly fired over role with CDC vaccine panel—wife calls it a ‘staggering turn of events’ ()
The only heart failure treatment of its kind: Learn the latest billing recommendations for Barostim procedures ()
Reimbursement expected to drive implementation of CCTA, coronary plaque analysis ()
FDA clears new stent-based coronary thrombectomy system ()
Cardiologists join chorus of voices urging Trump administration to kill cybersecurity proposal ()
A common word may be giving heart patients the wrong idea ()
Q&A: Cardiologist reviews key trends in pediatric electrophysiology for 2026 and beyond ()
Is IVL safe for patients with diabetes? ()
CPT code updates in 2026 will change how interventional cardiologists get paid ()
M-TEER still beneficial for high-risk patients with smaller mitral valve areas ()
Researchers receive $3.2M in federal funding to test new heart pump for children ()
Diabetes associated with much higher risk of sudden cardiac death ()
Match Day results put spotlight on interventional cardiology’s workforce woes ()
TAVR still a safe treatment option for immunocompromised patients ()
Pope welcomes cardiologists to Vatican City ()
Edwards Lifesciences shares positive outlook for 2026, pointing to continued importance of TAVR ()
FDA commissioner claims Biden administration hid heart risks of COVID-19 vaccines from public ()
FDA clears new left-heart access system from Atraverse Medical ()
Medtronic launches new diabetes tech integrated with Abbott sensor ()
FDA panel votes against approving first-of-its-kind heart failure device ()
Interventional cardiology groups unite to push the specialty forward ()
3-in-1 TAVR guidewire linked to faster procedures, less radiation ()
Stem cell company acquires 2 cardiology practices, calling them ‘the first of many’ ()
FDA announces Class I recall of patches used for heart surgery ()
Doctors still unsure about Trump’s heart health after ‘weird’ memo ()
AI has already transformed TAVR care—and the best is yet to come ()
Siemens Healthineers unveils new AI-powered CCTA software ()
Waiting is no longer ‘good medicine’: Data shows treating severe AS with TAVR before symptoms appear improves outcomes, reduces costs ()
‘Beer belly’ associated with multiple heart risks, especially in men ()
White House releases statement on Trump’s heart health, MRI results ()
Medicare data reveal ‘highly concerning’ TAVR trends—are hospital rankings to blame? ()